OPT-80 Phase III Study -A Multi-center, Double Blinded, Randomized, Parallel Group Study To Compare The Safety, Pharmacokinetics And Efficacy of OPT-80 With Vancomycin In Subjects With Clostridium Difficile-Associated Diarrhea (CDAD)
Phase of Trial: Phase III
Latest Information Update: 28 May 2018
Price : $35 *
At a glance
- Drugs Fidaxomicin (Primary) ; Vancomycin
- Indications Clostridium difficile infections
- Focus Registrational; Therapeutic Use
- Sponsors Astellas Pharma
- 27 Sep 2016 Status changed from recruiting to completed.
- 03 Feb 2016 Planned End Date changed from 1 Mar 2016 to 1 Dec 2016, according to ClinicalTrials.gov record.
- 03 Feb 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Dec 2016, according to ClinicalTrials.gov record.